Medicamen Biotech Board of Directors

Get the latest insights into the leadership at Medicamen Biotech. Learn about the experienced professionals guiding the company's strategy and governance.

NamePosition
Mr. Rahul Bishnoi Chairman
Mr. Ashwani Kumar Sharma Non Executive Director
Dr. Vimal Kumar Shrawat Non Executive Director
Mr. Sanjay Bansal Non Executive Director
Mr. Suresh Kumar Singh Non Executive Director
Mr. Arun Kumar Independent Director
Mr. Harish Pande Independent Director
Ms. Sangeeta Bishnoi Independent Director
Dr. Ravi Kumar Bansal Independent Director
Mrs. Sumita Dwivedi Independent Director

Medicamen Biotech Share price

MEDICAMEQ

346.6

3.95 (-1.13%)
NSE
BSE
Last updated on 4 Sep, 2025 | 15:58 IST
BUYSELL
Today's High

362.00

Today's Low

344.55

52 Week Low

341.70

52 Week High

630.00

The current prices are delayed, login to your account for live prices

Medicamen Biotech FAQs

The board at Medicamen Biotech consists of experienced professionals, including Mr. Rahul Bishnoi , Mr. Ashwani Kumar Sharma , and others, overseeing the company’s strategic and corporate governance.

Directors at Medicamen Biotech are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.

As of the latest update, Mr. Rahul Bishnoi is the current chairman at Medicamen Biotech.

Executive directors at Medicamen Biotech are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.

Yes, Medicamen Biotech adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.

At Medicamen Biotech, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.